117 related articles for article (PubMed ID: 37179558)
21. Neuroprotective role of chloroquine via modulation of autophagy and neuroinflammation in MPTP-induced Parkinson's disease.
Kartik S; Pal R; Chaudhary MJ; Nath R; Kumar M; Binwal M; Bawankule DU
Inflammopharmacology; 2023 Apr; 31(2):927-941. PubMed ID: 36715843
[TBL] [Abstract][Full Text] [Related]
22. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress.
Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ
Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450
[TBL] [Abstract][Full Text] [Related]
23. Mitochonic acid 5 ameliorates the motor deficits in the MPTP-induced mouse Parkinson's disease model by AMPK-mediated autophagy.
Wan J; Gao Y; Tan J; Yi S; Huang K; Liu Y; Chang D; Xie J; Chen S; Wu H
Folia Neuropathol; 2022; 60(3):329-337. PubMed ID: 36382486
[TBL] [Abstract][Full Text] [Related]
24. Treadmill Exercise Attenuates α-Synuclein Levels by Promoting Mitochondrial Function and Autophagy Possibly via SIRT1 in the Chronic MPTP/P-Induced Mouse Model of Parkinson's Disease.
Koo JH; Cho JY
Neurotox Res; 2017 Oct; 32(3):473-486. PubMed ID: 28656548
[TBL] [Abstract][Full Text] [Related]
25. The molecular mechanism of three novel peptides from C-phycocyanin alleviates MPTP-induced Parkinson's disease-like pathology in zebrafish.
Xu FH; Qiu YZ; Zhang Y; Yang FH; Ji MM; Liu KC; Jin M; Zhang SS; Li B
Food Funct; 2023 Jul; 14(13):6157-6171. PubMed ID: 37337786
[TBL] [Abstract][Full Text] [Related]
26. Neuroprotection of Andrographolide against Neurotoxin MPP
Prasertsuksri P; Kraokaew P; Pranweerapaiboon K; Sobhon P; Chaithirayanon K
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239873
[TBL] [Abstract][Full Text] [Related]
27. Anodal transcranial direct current stimulation prevents methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity by modulating autophagy in an in vivo mouse model of Parkinson's disease.
Lee SB; Kim HT; Yang HO; Jang W
Sci Rep; 2018 Oct; 8(1):15165. PubMed ID: 30310174
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotective effects of Tongtian oral liquid, a Traditional Chinese Medicine in the Parkinson's disease-induced zebrafish model.
Dongjie S; Rajendran RS; Xia Q; She G; Tu P; Zhang Y; Liu K
Biomed Pharmacother; 2022 Apr; 148():112706. PubMed ID: 35152046
[TBL] [Abstract][Full Text] [Related]
29. Anti-Inflammatory and Neuroprotective Effects of Morin in an MPTP-Induced Parkinson's Disease Model.
Hong DG; Lee S; Kim J; Yang S; Lee M; Ahn J; Lee H; Chang SC; Ha NC; Lee J
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142491
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic effects of rapamycin on MPTP-induced Parkinsonism in mice.
Liu K; Shi N; Sun Y; Zhang T; Sun X
Neurochem Res; 2013 Jan; 38(1):201-7. PubMed ID: 23117422
[TBL] [Abstract][Full Text] [Related]
31. Mangiferin, a natural glucoxilxanthone, inhibits mitochondrial dynamin-related protein 1 and relieves aberrant mitophagic proteins in mice model of Parkinson's disease.
Wang XL; Feng ST; Wang YT; Zhang NN; Guo ZY; Yan X; Yuan YH; Wang ZZ; Chen NH; Zhang Y
Phytomedicine; 2022 Sep; 104():154281. PubMed ID: 35752080
[TBL] [Abstract][Full Text] [Related]
32. Papaverine inhibits α-synuclein aggregation by modulating neuroinflammation and matrix metalloproteinase-3 expression in the subacute MPTP/P mouse model of Parkinson's disease.
Leem YH; Park JS; Park JE; Kim DY; Kang JL; Kim HS
Biomed Pharmacother; 2020 Oct; 130():110576. PubMed ID: 32768884
[TBL] [Abstract][Full Text] [Related]
33. Baicalin Represses C/EBP
Lei K; Shen Y; He Y; Zhang L; Zhang J; Tong W; Xu Y; Jin L
Oxid Med Cell Longev; 2020; 2020():8951907. PubMed ID: 32566108
[TBL] [Abstract][Full Text] [Related]
34. Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein.
Merghani MM; Ardah MT; Al Shamsi M; Kitada T; Haque ME
Neurotoxicology; 2021 May; 84():41-52. PubMed ID: 33549656
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the TLR/NF-
Su Y; Li M; Wang Q; Xu X; Qin P; Huang H; Zhang Y; Zhou Y; Yan J
Oxid Med Cell Longev; 2022; 2022():1837278. PubMed ID: 36589679
[TBL] [Abstract][Full Text] [Related]
36. Novel fatty acid-binding protein 3 ligand inhibits dopaminergic neuronal death and improves motor and cognitive impairments in Parkinson's disease model mice.
Haga H; Yamada R; Izumi H; Shinoda Y; Kawahata I; Miyachi H; Fukunaga K
Pharmacol Biochem Behav; 2020 Apr; 191():172891. PubMed ID: 32126223
[TBL] [Abstract][Full Text] [Related]
37. Mulberry fruit ameliorates Parkinson's-disease-related pathology by reducing α-synuclein and ubiquitin levels in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model.
Gu PS; Moon M; Choi JG; Oh MS
J Nutr Biochem; 2017 Jan; 39():15-21. PubMed ID: 27741433
[TBL] [Abstract][Full Text] [Related]
38.
Rai SN; Birla H; Singh SS; Zahra W; Patil RR; Jadhav JP; Gedda MR; Singh SP
Front Aging Neurosci; 2017; 9():421. PubMed ID: 29311905
[TBL] [Abstract][Full Text] [Related]
39. Deletion of autophagy-related gene 7 in dopaminergic neurons prevents their loss induced by MPTP.
Niu XY; Huang HJ; Zhang JB; Zhang C; Chen WG; Sun CY; Ding YQ; Liao M
Neuroscience; 2016 Dec; 339():22-31. PubMed ID: 27693472
[TBL] [Abstract][Full Text] [Related]
40. Tauroursodeoxycholic acid (TUDCA) is neuroprotective in a chronic mouse model of Parkinson's disease.
Cuevas E; Burks S; Raymick J; Robinson B; Gómez-Crisóstomo NP; Escudero-Lourdes C; Lopez AGG; Chigurupati S; Hanig J; Ferguson SA; Sarkar S
Nutr Neurosci; 2022 Jul; 25(7):1374-1391. PubMed ID: 33345721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
